Experimental and Theoretical Approaches to Monitor the Behavior of Bovine Liver Catalase in Interaction with a Binuclear Bismuth Complex by Zahral Alimoradi (18806973)

“…Synchronous fluorescence showed that tryptophan was more affected by enzyme–complex interactions than tyrosine. In addition, a cell viability test using the MTT method revealed that at its highest concentration, the Bi complex caused a decrease in the number of cells below 50% compared to the control, while cisplatin showed negative effects at all concentrations. …”

The peak energy of the fitted model function of the Ti Kβ spectra as a function of the instrumental broadening by C T Chantler (557430)

“…</strong> The peak energy of the fitted model function of the Ti Kβ spectra as a function of the instrumental broadening. The measured broadening of the spectrum of 1.24(4) eV and the asymmetry of the peak leads to a shift of peak position of 0.25 eV or 50 ppm.…”

Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index by Nicole Bechmann (5220479)

“…We synthesized a series of NO-releasing SERMs (NO-SERMs) and the corresponding SERMs (after NO release) derived from a triaryl olefin lead. …”

Location and complexity of ramifications within the NCTI. by Robert Arnold (3478271)

Expression of vIL-6, vGPCR, and vFLIP in PDLSCs transfected with their expression vectors. by Yao Ding (1429924)

Effect of cannabinoids on the viability of macrophages J774.1. by Bruno Musetti (9527085)

Anti-DNase II antibody detects recombinant DNase II protein expression in the mammalian ExpiCHO cell system. by Jing Wang (6206297)

Risk factors for <i>Schistosoma haematobium</i> infection. by Lydia Trippler (10136316)

Comparison of time requirements (hours) for traditional serum bactericidal assay (SBA) and novel flow cytometry-based SBA. by Orianna Poteete (19251220)

Fibroblast markers determined by IF and western blot. by Pascale Plaisancié (13531638)

Distribution of susceptibility to serum killing among <i>E</i>. <i>coli</i> bloodstream infection (BSI) isolates. by Orianna Poteete (19251220)

Morphological characteristics of fibroblastic cell lines. by Pascale Plaisancié (13531638)

Workflow and duration differences between traditional serum bactericidal assay (SBA) and flow cytometry-based SBA methods. by Orianna Poteete (19251220)

MMV291 disrupts actin-dependent apicoplast segregation and induces a partial delayed death phenotype. by Madeline G. Dans (14193815)

“…<p><b>(A) i</b> Representative panels from live cell imaging of apicoplast targeted acyl carrier protein (ACP) tagged with GFP revealed that treatment of trophozoites for 24 hours with both 5 μM and 10 μM MMV291 (10 and 20 × EC₅₀) disrupted apicoplast segregation, resulting in an increase in abnormal apicoplast clumping at schizonts. …”

STM2457 and PD98059 promoted PRV replication <i>in vitro.</i> by Lucai Wang (22050158)

Descriptive statistics. by Giulio Contemori (7019876)

“…In this cross-sectional study, our objective was to evaluate the suitability of a newly developed, self-administered, online tool for examining age-related differences in memory performance under dual-tasking. 337 healthy adults aged 50–90 underwent a visual memory test (Memo) under both single and dual-task conditions (attend to auditory letters). …”

Effect of sgRNA-mediated knockout on PRV replication in PK-15 cells. by Lucai Wang (22050158)

Relationship between the antioxidant effect of the extracts and their cannabinoid content. by Bruno Musetti (9527085)

RZC purification of 6-hb dimer. by Jason Sentosa (16617743)

Supplementary Material for: Visit-to-Visit Variability in Total Cholesterol Correlates with the Progression of Renal Function Decline in a Chinese Community-Based Hypertensive Popu... by Yan Y. (3096201)

“…TC variability was measured using standard deviation (SD), average successive variability (ASV), coefficient of variation (CV), and variability independent of the mean (VIM). The endpoint of this study was progression of renal function decline defined as a decrease in estimated glomerular filtration rate (eGFR) ≥30% and to a level <60 mL/min/1.73 m² during follow-up if the baseline eGFR was ≥60 mL/min/1.73 m², or a decrease in eGFR ≥50% during follow up if the baseline eGFR was <60 mL/min/1.73 m². …”